Newsletter

Newsletter #002

15/09/2020 | Read

Newsletter #001

05/06/2020 | Read

Sign up to stay informed

Subscribe here to our newsletter and stay updated on the latest developments:

Latest news

Courtney Worrell, psychiatric research specialist involved in EU-PEARL WP 4

2020-12-02

Stakeholder Workshop: Join us in shaping the future of clinical trials!

2020-09-14

EU-PEARL’s second GAM is about to kick off in a virtual format

2020-09-14

The “magic” of public-private partnerships

2020-09-13

Aude Mouline, mother of Titouan, 10, diagnosed with NF

2020-09-12

Acknowledgement

“EU-PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966-2. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA”.

About IMI

The Innovative Medicines Initiative is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). It is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It works by facilitating collaboration between the key players involved in health research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world’s biggest public-private partnership (PPP) in the life sciences.

Legal notice | Privacy policy

Contact

info@eu-pearl.eu

Newsletter

Newsletter #002

Newsletter #001

Sign up to stay informed

Latest news

Signup to stay informed